Bioluminescence is a leading US biotechnology venture capital firm investing in the future of medicine. We are inspired by the accelerating pace of biomedical innovation and its recent impact on humanity. We are mission-driven – investing our time, energy, and capital into translating transformative science into next-generation medicines that will impact patients. We believe that, as long as we continue to succeed in this endeavor, then strong financial returns will follow. The firm focuses investments on four areas: Breakthrough Biology, Drug Discovery Platforms, Genetic Medicines Platforms, and Computational Biology Platforms.
Company Details
- Employees
- 3
- Address
- 501 2nd Street, San Francisco,california 94107,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.bioluminescence.com
- Keywords
- Earlybird Venture Capital.
- HQ
- San Francisco, California
Bioluminescence Ventures Questions
Bioluminescence Ventures's website is http://www.bioluminescence.com
Bioluminescence Ventures's LinkedIn profile is https://www.linkedin.com/company/bioluminescence-ventures
Bioluminescence Ventures has
3 employees.
View email and phone details for 3
employees at Bioluminescence Ventures.
Bioluminescence Ventures's industry is
Biotechnology Research
Bioluminescence Ventures's top competitors are
Hanwha Group,
Ikigai Bioventures,
Bioculture Group,
Omega Therapeutics,
Earlybird Venture Capital,
Recode Therapeutics,
Agent Capital,
Double Point Ventures,
Abingworth,
Cerevance.
Bioluminescence Ventures's categories are Biotechnology Research
